Breadcrumb Home Media centre Media releases Media Releases Quick Explore In the news Featured Stories Collaborative partnership between Sikkim Govt and Cipla Foundation to bring Science Education closer to students #InhalersHainSahi - #BerokZindagi is back to inspire people with asthma to live a life without limits Cipla acquires novel anti-infective Elores to further anti- microbial stewardship in critical care in India Breathe Free Lanka partners with Novartis in Sri Lanka to provide Ultibro® Breezhaler® Year 201920182017201620152014201320122010 Search News Apply Media Releases 2019 Cipla Foundation awards scholarships to students from Goa College of Pharmacy Collaborative partnership between Sikkim Govt and Cipla Foundation to bring Science Education closer to students #InhalersHainSahi - #BerokZindagi is back to inspire people with asthma to live a life without limits Cipla acquires novel anti-infective Elores to further anti- microbial stewardship in critical care in India Breathe Free Lanka partners with Novartis in Sri Lanka to provide Ultibro® Breezhaler® Alvotech and Cipla Gulf enter into a partnership for the Commercialization of key biosimilar in select emerging markets Cipla USA furthers AMR stewardship with acquisition of key anti-infective ZEMDRI™ (IV Plazomicin) InvaGen (a Cipla subsidiary) receives final approval for generic version of Pfizer’s Lyrica® (Pregabalin Capsules, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg) Cipla receives final approval for generic version of Gilead Sciences, Inc’s Letairis® (Ambrisentan Tabs, 5mg & 10mg) Cipla appoints Dr. Raju Mistry as Global Chief People Officer CIPLA MEDPRO ACQUIRES A STAKE IN CONNECTED HEALTH COMPANY BRANDMED Cipla Technologies LLC and Pulmatrix enter into Definitive Agreement for the Development and Commercialization of Pulmazole Cipla launches Niveoli™, India’s first extrafine ICS-LABA combination HFA inhaler Cipla EU and Jiangsu Acebright enter into joint venture Cipla and Wellthy Therapeutics Announce Partnership to offer Digital Therapeutics for Diabetes and Cardiovascular Diseases Cipla receives final approval for generic version of Eli Lilly & Co.’s Adcirca® (Tadalafil Tablets 20mg) Cipla receives final approval for generic version of Pfizer’s Depo-Provera® (Medroxyprogesterone Injectable, 150mg/mL)
